|
| 35918741 | Beyond COVID-19 and lessons learned in the United States. | Transfus Med | 2023 |
| 37919210 | Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases. | Transfus Med Rev | 2023 |
| 37005871 | Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium. | Transfusion | 2023 |
| 36550639 | Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donors. | Transfusion | 2023 |
| 33174258 | Buffy coat platelets coming to America: Are we ready? | Transfusion | 2021 |
| 34928960 | Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. | PLoS Med | 2021 |
| 34761397 | Powassan virus: What is the risk to the blood supply? | Transfusion | 2021 |
| 34551093 | Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018. | Blood Adv | 2021 |
| 34689966 | Blood Product (Donor) Noninfectious and Infectious Testing and Modification. | Clin Lab Med | 2021 |
| 34247970 | Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient. | Transfus Apher Sci | 2021 |
| 34213026 | Blood transfusions in gunshot-wound-related emergency department visits and hospitalizations in the United States. | Transfusion | 2021 |
| 34287930 | A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availability. | Transfusion | 2021 |
| 33440086 | (A Little) Clarity on Convalescent Plasma for Covid-19. | N Engl J Med | 2021 |
| 32254064 | Deployment of convalescent plasma for the prevention and treatment of COVID-19. | J Clin Invest | 2020 |
| 32589286 | Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States. | Transfusion | 2020 |
| 32869327 | Comparative changes of pre-operative autologous transfusions and peri-operative cell salvage in the United States. | Transfusion | 2020 |
| 32748963 | Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network. | Transfusion | 2020 |
| 32275069 | Financial analysis of large-volume delayed sampling to reduce bacterial contamination of platelets. | Transfusion | 2020 |
| 32562440 | Evaluation and improvement of blood donor educational materials: results from a multicenter randomized controlled trial. | Transfusion | 2020 |
| 32542718 | Is SARS-CoV-2 transfusion transmitted? | Transfusion | 2020 |
| 32163599 | It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4. | Transfusion | 2020 |
| 30520046 | Frequent blood donation and offspring birth weight-a next-generation association? | Transfusion | 2019 |
| 30950091 | The argument(s) for lowering the US minimum required content of apheresis platelet components. | Transfusion | 2019 |
| 30461026 | The argument(s) for lowering the US minimum required content of apheresis platelet components. | Transfusion | 2019 |
| 29542121 | Report of a workshop on ensuring sustainable access to safe blood in developing countries: International Blood Safety Forum, March 24, 2017. | Transfusion | 2018 |
| 30204949 | Donor screening for hepatitis B: hepatitis B surface antigen-a belt, suspenders, and another belt? | Transfusion | 2018 |
| 28043179 | The cobas® 6800/8800 System: a new era of automation in molecular diagnostics. | Expert Rev Mol Diagn | 2017 |
| 27788336 | Zika and the Blood Supply: A Work in Progress. | Arch Pathol Lab Med | 2017 |
| 27515226 | The association between frequency of blood donation and the occurrence of low birthweight, preterm delivery, and stillbirth: a retrospective cohort study. | Transfusion | 2016 |
| 27732721 | Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. | JAMA | 2016 |
| 25438646 | It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. | Transfusion | 2015 |
| 25677928 | Qui custodiet ipsos custodes? | Transfusion | 2015 |
| 25688854 | A clinical governance framework for blood services. | Vox Sang | 2015 |
| 24617628 | How safe is safe enough, who decides and how? From a zero-risk paradigm to risk-based decision making. | Transfusion | 2014 |
| 25212423 | Screening for babesiosis: where is the policy? | Transfusion | 2014 |
| 25403825 | Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing. | Transfusion | 2014 |
| 25188721 | Emerging microbial threats to the United States blood supply. | Curr Opin Hematol | 2014 |
| 22690676 | Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century. | Transfusion | 2013 |
| 23461271 | Survey of methods used to detect bacterial contamination of platelet products in the United States in 2011. | Transfusion | 2013 |
| 21933190 | International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. | Vox Sang | 2012 |
| 22751760 | Red blood cell transfusion: a clinical practice guideline from the AABB*. | Ann Intern Med | 2012 |
| 22223606 | Causes of alternative pathway dysregulation in dense deposit disease. | Clin J Am Soc Nephrol | 2012 |
| 22293430 | How can the blood transfusion medicine community contribute to public health in tough economic times? | J Infect Dis | 2012 |
| 21235597 | Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. | Transfusion | 2011 |
| 21784901 | Allelic variants of complement genes associated with dense deposit disease. | J Am Soc Nephrol | 2011 |
| 20136789 | The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. | Vox Sang | 2010 |
| 20955130 | Complexity of risk for transfusion malaria and differentiated response to risk management. | Med J Aust | 2010 |
| 20546548 | Human herpesvirus-8: what (not) to do redux? | Transfusion | 2010 |
| 20553433 | Modeling the risk of an emerging pathogen entering the Canadian blood supply. | Transfusion | 2010 |
| 19170988 | The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments. | Transfusion | 2009 |